Dian Diagnostics released its performance for the first three quarters, with a net profit attributable to the parent company of 56.7048 million yuan, a decrease of 56.67%

Dian Diagnostics released its third-quarter report for 2025, with operating revenue for the first three quarters at 7.566 billion yuan, a year-on-year decrease of 18.28%. The net profit attributable to the parent company was 56.7048 million yuan, a year-on-year decline of 56.67%; the net profit excluding non-recurring gains and losses was 35.5519 million yuan, a year-on-year decrease of 73.50%. The basic earnings per share were 0.0928 yuan